|
Methylcobalamin It is very useful drug in treatment of peripheral neuropathy, diabetic neuropathy and is also useful in preliminary treatment of amyotrophic lateral sclerosis. These medicines have been prepared under sterelised conditions. Many pateints have been benifited from MethylCobalamin. Supplementation with megadoses of methylcobalamin has been advocated to protect the cognitive function of patients suffering chronic fatique syndrom, stroke, depression,Alzheimer disease and other neurological diseases. The rationale is that methycobalamin may help to remove brain-damaging levels of the neurotransmitter glutamate. Methylcobalamin has reported to have been used to reduce neurotoxicity and lower excess glutamate levels, resulting in the reduction of fatigue, stabilisation of mood, improvement of memory and executive function. Some specifications of these drugs are:
Identifiers CAS number 13422-55-4 ATC code B03BA05 PubChem CID 6436232 Chemical data Formula C63H91CoN13O14P Mol. mass 1344.40 g/mol Therapeutic considerations Pregnancy cat. ? Legal status ? Routes oral,sublingual,injection.
|
